Synthesis of new (difluoromethylphosphono)azadisaccharides designed as bisubstrate analogue inhibitors for GlcNAc:β-1,4 glycosyltransferases

Bioorganic and Medicinal Chemistry Letters

Volumn 10, Issue 13, 2000, Pages 1483-1486

  Gautier Lefebvre, Isabelle ^a   Behr, Jean Bernard ^a   Guillerm, Georges ^a   Ryder, Neil S ^b  

^a UMR 6519   (France)

^b NOVARTIS RESEARCH INSTITUTE   (Austria)

Author keywords

[No Author keywords available]

Indexed keywords

AMINOSUGAR; CARBOHYDRATE DERIVATIVE; CHITIN SYNTHASE; GLYCOSYLTRANSFERASE INHIBITOR; PYRROLIDINE DERIVATIVE;

AMINATION; ANTIFUNGAL ACTIVITY; ARTICLE; ASPERGILLUS FUMIGATUS; CANDIDA ALBICANS; CRYPTOCOCCUS NEOFORMANS; DRUG DESIGN; DRUG INHIBITION; DRUG SCREENING; DRUG SYNTHESIS; ENZYME ACTIVITY; MICROSPORUM CANIS; NONHUMAN; SACCHAROMYCES CEREVISIAE; TRICHOPHYTON MENTAGROPHYTES;

ANTIFUNGAL AGENTS; AZA COMPOUNDS; CHITIN SYNTHASE; DISACCHARIDES; DRUG DESIGN; ENZYME INHIBITORS; GLYCOSYLTRANSFERASES; MITOSPORIC FUNGI; MOLECULAR STRUCTURE; SACCHAROMYCES CEREVISIAE;

ARTHRODERMA BENHAMIAE; ASPERGILLUS FUMIGATUS; CANDIDA ALBICANS; CANIS; FILOBASIDIELLA NEOFORMANS; MICROSPORUM CANIS; SACCHAROMYCES CEREVISIAE; TRICHOPHYTON;

EID: 0034601137     PISSN: 0960894X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0960-894X(00)00263-8     Document Type: Article

References (35)

1. (a) Stütz, A.E. Angew Chem., Int. Ed. Engl. 1996, 35, 1926.
2. (b) Dwek, R. A. Chem. Rev. 1996, 96, 683.
3. (c) Smith, C. A.; Davis, T.; Anderson, D.; Solam, L.; Beekman, M. P.; Jerzy, R.; Tersu, R.; Dower, D. K.; Cosman, D.; Goodwin, R. G. Science 1990, 248, 1019.
4. (d) Warki, A. Glycobiology 1993, 3, 97.
5. (e) Isono, K.; Suzuki, S. Heterocycles 1979, 13, 333.
6. Dennis, K. W.; Laferte, S.; Waghorne, C.; Breitman, M. L.; Kerbel, R. S. Science 1987, 236, 582. Dennis, J. W. Cancer Survey 1988, 7, 573. Springer, T. A.; Lasky, L. A. Nature 1991, 349, 193. Osborn, L. Cell 1990, 62, 3. Olden, K.; Breton, P.; Grzegorzewski, K.; Yasuda, Y.; Gause, B. L.; Oredipe, O. A.; Newton, S. A.; White, S. L. Pharmacol. Ther. 1991, 50, 285; Goss, P. E.; Baptiste, J.; Fernandes, B.; Baker, M.; Dennis, J. W. Cancer Res. 1994, 54, 1450.
7. Dennis, K. W.; Laferte, S.; Waghorne, C.; Breitman, M. L.; Kerbel, R. S. Science 1987, 236, 582. Dennis, J. W. Cancer Survey 1988, 7, 573. Springer, T. A.; Lasky, L. A. Nature 1991, 349, 193. Osborn, L. Cell 1990, 62, 3. Olden, K.; Breton, P.; Grzegorzewski, K.; Yasuda, Y.; Gause, B. L.; Oredipe, O. A.; Newton, S. A.; White, S. L. Pharmacol. Ther. 1991, 50, 285; Goss, P. E.; Baptiste, J.; Fernandes, B.; Baker, M.; Dennis, J. W. Cancer Res. 1994, 54, 1450.
8. Dennis, K. W.; Laferte, S.; Waghorne, C.; Breitman, M. L.; Kerbel, R. S. Science 1987, 236, 582. Dennis, J. W. Cancer Survey 1988, 7, 573. Springer, T. A.; Lasky, L. A. Nature 1991, 349, 193. Osborn, L. Cell 1990, 62, 3. Olden, K.; Breton, P.; Grzegorzewski, K.; Yasuda, Y.; Gause, B. L.; Oredipe, O. A.; Newton, S. A.; White, S. L. Pharmacol. Ther. 1991, 50, 285; Goss, P. E.; Baptiste, J.; Fernandes, B.; Baker, M.; Dennis, J. W. Cancer Res. 1994, 54, 1450.
9. Dennis, K. W.; Laferte, S.; Waghorne, C.; Breitman, M. L.; Kerbel, R. S. Science 1987, 236, 582. Dennis, J. W. Cancer Survey 1988, 7, 573. Springer, T. A.; Lasky, L. A. Nature 1991, 349, 193. Osborn, L. Cell 1990, 62, 3. Olden, K.; Breton, P.; Grzegorzewski, K.; Yasuda, Y.; Gause, B. L.; Oredipe, O. A.; Newton, S. A.; White, S. L. Pharmacol. Ther. 1991, 50, 285; Goss, P. E.; Baptiste, J.; Fernandes, B.; Baker, M.; Dennis, J. W. Cancer Res. 1994, 54, 1450.
10. Dennis, K. W.; Laferte, S.; Waghorne, C.; Breitman, M. L.; Kerbel, R. S. Science 1987, 236, 582. Dennis, J. W. Cancer Survey 1988, 7, 573. Springer, T. A.; Lasky, L. A. Nature 1991, 349, 193. Osborn, L. Cell 1990, 62, 3. Olden, K.; Breton, P.; Grzegorzewski, K.; Yasuda, Y.; Gause, B. L.; Oredipe, O. A.; Newton, S. A.; White, S. L. Pharmacol. Ther. 1991, 50, 285; Goss, P. E.; Baptiste, J.; Fernandes, B.; Baker, M.; Dennis, J. W. Cancer Res. 1994, 54, 1450.
11. Dennis, K. W.; Laferte, S.; Waghorne, C.; Breitman, M. L.; Kerbel, R. S. Science 1987, 236, 582. Dennis, J. W. Cancer Survey 1988, 7, 573. Springer, T. A.; Lasky, L. A. Nature 1991, 349, 193. Osborn, L. Cell 1990, 62, 3. Olden, K.; Breton, P.; Grzegorzewski, K.; Yasuda, Y.; Gause, B. L.; Oredipe, O. A.; Newton, S. A.; White, S. L. Pharmacol. Ther. 1991, 50, 285; Goss, P. E.; Baptiste, J.; Fernandes, B.; Baker, M.; Dennis, J. W. Cancer Res. 1994, 54, 1450.
12. (a) Sinnott, M. L. J. Chem. Rev. 1990, 90, 1171 and ref therein.
13. (b) Timmers, C. M.; Dekker, M.; Buijsman, R. C.; Van der Marel, G. A.; Ethell, B.; Anderson, G.; Burchell, B.; Mulder, G. J.; Van Boom, J. H. Bioorg. Med. Chem. Lett. 1997, 7, 1501.
14. (c) Palcic, M. M.; Heerse, L. D.; Srivastava, O. P.; Hindsgaul, O. J. Biol. Chem. 1989, 264, 17174.
15. (d) Noort, D.; Van der Marel, G. A.; Van der Gen, A.; Mulder, G. J.; Van Boom, J. H. Red. Trav. Chim. Pays-Bas 1991, 110, 53 and ref therein.
16. (a) Wischnat, R.; Martin, R.; Wong, C. H. J. Org. Chem. 1998, 63, 8361.
17. (b) Takaoka, Y.; Kajimoto, T.; Wong, C. H. J. Org. Chem. 1993, 58, 4809.
18. (c) Palcic, M. M.; Ripka, J.; Kaur, K. J.; Shoreibah, M.; Hindsgaul, O.; Pierce, M. J. Biol. Chem. 1990, 265, 6759.
19. (d) Khan, S. H.; Crawley, S. C.; Kane, O.; Hindsgaul, O. J. Biol. Chem. 1993, 268, 2468.
20. Hashimoto H., Endo T., Kajihara Y. J. Org. Chem. 62:1997;1914.
21. Field R.A., Neville D.C.A., Smith R.W., Ferguson M. Bioorg. Med. Chem. Lett. 4:1994;391.
22. Behr, J.-B.; Mvondo Evina, C.; Phung, N.; Guillerm, G. J. Chem. Soc. Perkin Trans. 1 1997, 1599.
23. N-Allyl glycosylamines are easily hydrolized back to the parent sugar (Spevak, W.; Dasgupta, F.; Hobbs, C. J.; Nagy, J. O. J. Org. Chem. 1996, 61, 3417) so that 2a,b could not be purified and were reacted as crude material.
24. Barker R., Fletcher H.G. J. Org. Chem. 26:1961;4605.
25. Lay L., Nicotra F., Paganini A., Pangrazio C., Panza L. Tetrahedron Lett. 34:1993;4555.
26. Santoyo-Gonzalez, F.; Uriel, C.; Calvo-Asin, J. A. Synthesis 1998, 1787.
27. Zhong, Y.-L.; Shing, T.K.M. J. Org. Chem. 1997, 62, 2622.
28. 2O 101 MHz) 10.4 ppm (t).
29. Cabib, E.; Shaw, J.A.; Mol, P.C.; Bowers, B.; Choi, W.-J. in Biochemistry and Molecular Biology; Springer Verlag, Ed.; 1996, pp 243.
30. 3 CFU/mL. Each assay was performed with a duplicate series of drug dilutions. In brief, the assays were done in RPMI 1640 medium buffered to pH 7.0 with MOPS buffer, incubated at 35 °C for 48 h. C. neoformans and A. fumigatus were tested in the same assay, except that incubations were for 72 h. The dermatophytes T. mentagrophytes and M. canis were incubated at 30 °C for 7 days. The MIC was defined as the lowest concentration of the drug causing 80% inhibition of fungal growth in comparison with untreated controls.
31. National Committee for Clinical Laboratory Standards. Reference method for broth dilution antifungal susceptibility testing of yeasts; approved standard. NCCLS Document M27-A. NCCLS, Wayne, Pa, USA, 1997.
32. Ryder N.S., Wagner S.I., Leitner I. Antimicrob. Agents Chemother. 42:1998;1057.
33. Masson J.M., Guillermet V., Marinos E., Le Goffic F. Eur. J. Med. Chem. 22:1987;377.
34. Cabib E. Methods Enzymol. 28:1972;572.
35. Ruiz-Herrera J., Bartinicki-Garcia S. J. Gen. Microbiol. 97:1976;241.